The role of soluble B cell maturation antigen as a biomarker in multiple myeloma
| Autor: | Mohammed Alomari, Chutima Kunacheewa, Elisabet E. Manasanch |
|---|---|
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | Leukemia & Lymphoma. 64:261-272 |
| ISSN: | 1029-2403 1042-8194 |
| Popis: | Currently used stratification models in myeloma precursor disease as well as staging systems and response criteria in myeloma have limitations including failure to identify functionally high-risk myeloma patients. B-cell maturation antigen, a transmembrane glycoprotein required for long-lived plasma cells, is specific and expressed by myeloma cells. When it sheds from the surface of myeloma cells it can be measured in the blood as serum (sBCMA) and correlated with clinical outcomes in myeloma precursor disease as well as in active myeloma. We performed a literature review using PubMed and found 825 articles since 1992 of which any articles related to sBCMA were reviewed. These studies show the potential of sBCMA to become an important biomarker in myeloma. Here, we describe the potential advantages of sBCMA in the biology, diagnosis, prognosis, and surveillance of myeloma, while also reviewing the challenges that lie ahead before it can be implemented as a clinical tool. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|